Latest Articles

Publication Date
An Overview of Endometriosis and Potential Pharmacogenetic Targets.

Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissue outside the uterine cavity. It affects approximately 10-15% of women of reproductive age globally and is characterized …

Published: Feb. 25, 2026, midnight
Dynamics of diaphragmatic endometriosis with thoracic endometriosis-related pneumothorax.

Pneumothorax that occurs during menstruation is called catamenial pneumothorax; however, it is also called thoracic endometriosis-related pneumothorax (TERP) because of its etiology. Because of its high postoperative recurrence rate, TERP …

Published: Feb. 25, 2026, midnight
Systems-level actions of luteolin in female reproductive disorders: from molecular mechanisms to clinical translation.

Female reproductive disorders represent a major global health challenge. Despite their clinical heterogeneity, these conditions share core pathological mechanisms including oxidative stress, chronic inflammation, hormonal imbalance, metabolic dysfunction, extracellular matrix …

Published: Feb. 25, 2026, midnight
Increased C-Reactive Protein Concentrations During Menstruation May Be Important for the Pathophysiology of Endometriosis and Possibly for Adhesion Formation-A Systematic Review.

Objectives: The peritoneal cavity is a cavity outside the bloodstream, with a specific hormonal, immunological and microbiological micro-environment distinct from plasma. The mesothelial cells lining the peritoneal cavity react within …

Published: Feb. 24, 2026, midnight
The role of gut microbiota in modulating estrogen in the inflammatory milieu of endometriosis: A molecular and pathophysiological perspective.

Endometriosis is a prevalent estrogen-dependent chronic inflammatory condition that affects millions of women of reproductive age worldwide. It is characterized by the growth of endometrial tissue outside the uterine cavity, …

Published: Feb. 24, 2026, midnight
Endometrial cancer, Bellet (Acto): "Ensure access to new therapies nationwide." - lamilano.it

Endometrial cancer, Bellet (Acto): "Ensure access to new therapies nationwide." lamilano.it

Published: Feb. 23, 2026, 5:18 p.m.
Endometrial cancer, Campagnoli (GSK): "Immunotherapy increases overall survival." - lamilano.it

Endometrial cancer, Campagnoli (GSK): "Immunotherapy increases overall survival." lamilano.it

Published: Feb. 23, 2026, 5:15 p.m.
Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." - lamilano.it

Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." lamilano.it

Published: Feb. 23, 2026, 5:12 p.m.
PCOS Long-Term Health Risks: From Infertility And Type 2 Diabetes To Heart Disease And Endometrial Cancer - TheHealthSite

PCOS Long-Term Health Risks: From Infertility And Type 2 Diabetes To Heart Disease And Endometrial Cancer TheHealthSite

Published: Feb. 23, 2026, 1:56 p.m.
Endometrial cancer: AIFA approves immunotherapy with chemotherapy for all patients. - lamilano.it

Endometrial cancer: AIFA approves immunotherapy with chemotherapy for all patients. lamilano.it

Published: Feb. 23, 2026, 1:30 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!